Suchergebnisse - "Fajgenbaum, David C."

PubPharm (5)

1

Transcriptome and unique cytokine microenvironment of Castleman disease

enthalten in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc | 2022

von Wing, A. | Xu, J. | Meng, W. | +12

2

Is severe COVID-19 a cytokine storm syndrome : a hyperinflammatory debate

enthalten in: Current opinion in rheumatology | 2021

von Mehta, P. | Fajgenbaum, D.

3

Type I IFN response associated with mTOR activation in the TAFRO subtype of idiopathic multicentric Castleman disease

enthalten in: JCI insight | 2020

von Pai, R. | Japp, A. | Gonzalez, M. | +12

4

Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman disease

enthalten in: The Journal of clinical investigation | 2019

von Fajgenbaum, D. | Langan, R. | Japp, A. | +20

CommentIn: J Clin Invest. 2019 Oct 1;129(10):4086-4088. - PMID 31524635

5

HHV-8-negative, idiopathic multicentric Castleman disease : novel insights into biology, pathogenesis, and therapy

enthalten in: Blood | 2014

von Fajgenbaum, D. | van Rhee, F. | Nabel, C.

1
[1]